Hosted on MSN29d
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense ...
Yahoo Finance29d
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous ...
FierceBiotech29d
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Medtronic previously set the stage for the technology with an FDA approval in 2021 for deep-brain stimulation hardware that could sense and record changes in local electric field potentials.
News Medical23d
Medtronic receives FDA approval for BrainSense Adaptive DBS technology
Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...
Nasdaq29d
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology†, introducing aDBS for people living with Parkinson's. This feature personalizes ...
Healio29d
FDA approves first adaptive deep brain stimulation system for Parkinson’s disease
Image: Adobe Stock Participants were fitted with either subthalamic nucleus or globus pallidus internus DBS leads connected to a Medtronic Percept PC neurostimulator. The study, which compared ...
Benzinga.com29d
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS ...